Bowel 中文

概述

神经源性膀胱和肠道治疗包括一些可以帮助您控制排尿或排便时间的治疗方案。脊髓损伤有时会扰乱大脑与控制膀胱与肠功能的脊髓神经之间的通讯。这可能会导致膀胱和肠功能障碍，该障碍又被称为“神经源性膀胱”或“神经源性肠”。多发性硬化症或脊柱裂患者可能也有类似的问题。

神经源性膀胱的体征和症状可能包括膀胱失控、无法排空膀胱、尿频和尿路感染。

神经源性肠的体征包括排便失控、便秘、排便频繁和排便不足。

神经源性膀胱患者的膀胱治疗方案包括：

用药。您的医生可能开一些药物来改善膀胱功能。这些药物可能有助于减少膀胱收缩（膀胱收缩会使您有排尿的冲动）、降低排尿频率、改善膀胱失控、增加膀胱储存量或帮助排空膀胱。
清洁间歇性导尿（CIC）。在 CIC 中，您或一位医护专业人员将在白天多次将一根细管穿过尿道插入膀胱，以排空膀胱。
持续导尿。医护专业人员可能将导管穿过尿道或腹壁插入膀胱，以持续排空膀胱。
手术干预。在膀胱控制方面训练有素的医生可能施行膀胱重建手术，解决或改善膀胱症状。

针对神经源性肠患者的肠治疗方案包括：

用药。医生可能会开药以控制排便的时间和连贯性。
肛门冲洗。肛门冲洗是一种较新的肠道管理保守疗法。液体通过带有可充气球囊的导管灌入，以减少便秘并帮助有效排便和排便控制。
手术干预。接受过肠外科手术培训的外科医生可以进行重建手术，以解决肠道控制方面的困难。

妙佑医疗国际明尼苏达州院区的脊髓损伤康复项目为神经源性膀胱或肠患者提供多种膀胱和肠道治疗方案。

在 Mayo Clinic 治疗

April 29, 2022

Abrams GM, et al. Chronic complications of spinal cord injury and disease. https://www.uptodate.com/contents/search. Accessed Feb. 7, 2022.
Neurogenic bladder? Urology Care Foundation. https://www.urologyhealth.org/urology-a-z/n/neurogenic-bladder. Accessed Feb. 7, 2022.
Bowel control problems (fecal incontinence). National Digestive Diseases Information Clearinghouse. https://www.niddk.nih.gov/health-information/digestive-diseases/bowel-control-problems-fecal-incontinence. Accessed Feb. 7, 2022.
Maitin IB, et al., eds. Neurogenic bowel & bladder. In: Current Diagnosis & Treatment: Physical Medicine & Rehabilitation. New York, N.Y.: McGraw-Hill Education; 2015. http://accessmedicine.mhmedical.com. Accessed Feb. 7, 2022.
Provider profile. CARF International. http://www.carf.org/providerProfile.aspx?cid=8020. Accessed Feb. 7, 2022.
Kelly MS. Malone antegrade continence enema vs. cecostomy vs. transanal irrigation—What is new and how do we counsel our patients? Current Urology Reports. 2019; doi:10.1007/s11934-019-0909-1.
Braswell-Pickering EA. Allscripts EPSi. Mayo Clinic. Oct. 15, 2021.

1. Periodic health examination. 1992 update: 2. Routine prenatal ultrasound screening. Canadian Task Force on the Periodic Health Examination. Can Med J. 1992;147(5):627–33. [PMC free article] [PubMed] [Google Scholar]

2. Society of Obstetricians and Gynaecologists of Canada. Guidelines for the performance of ultrasound examination in obstetrics and gynaecology. J Soc Obstet Gynaecol Can. 1995;17:263–6. [Google Scholar]

3. Society of Obstetricians and Gynaecologists of Canada. Obstetric/ gynaecologic ultrasound [policy statement] J Soc Obstet Gynaecol Can. 1997;65:871–2. [Google Scholar]

4. Saari-Kemppainen A, Karjalainen O, Ylostalo P, Heinonen OP. Ultrasound screening and perinatal mortality: controlled trial on systematic one-stage screening in pregnancy. The Helsinki Ultrasound Trial. Lancet. 1990;336(8712):387–91. [PubMed] [Google Scholar]

5. Leivo T, Tuominen R, Saari-Kemppainen A, Ylostalo P, Karjalainen O, Heinonen OP. Cost-effectiveness of one-stage ultrasound screening in pregnancy: a report from the Helsinki ultrasound trial. Ultrasound Obstet Gynecol. 1996;7(5):309–14. [PubMed] [Google Scholar]

6. Long G, Sprigg A. A comparative study of routine versus selective fetal anomaly ultrasound scanning. J Med Screen. 1998;5(1):6–10. [PubMed] [Google Scholar]

7. Nicolaides KH, Snijders RJ, Gosden CM, Berry C, Campbell S. Ultrasonographically detectable markers of fetal aneuploidy. Lancet. 1992;340:704–7. [PubMed] [Google Scholar]

8. Bromley B, Lieberman E, Shipp TD, Benacerraf BR. The genetic sonogram: a method of risk assessment for Down syndrome in the second trimester. J Ultrasound Med. 2002;21(10):1087–96. [PubMed] [Google Scholar]

9. Stene J, Stene E, Mikkelsoen M. Risk for chromosome abnormality at amniocentesis following a child with a non-inherited chromosome aberration. Prenatal Diagn. 1984;4 (special issue):81–95. [PubMed] [Google Scholar]

10. Warburton D. Genetic Factors Influencing Aneuploidy Frequency.; In: Dellarco VL, Voytek PK, Hollaender A, editors. Aneuploidy: etiology and mechanisms. ; New York: Plenum. 1985. pp. 133–48. [Google Scholar]

11. Society of Obstetricians and Gynaecologists of Canada. Guidelines for health care providers involved in prenatal screening and diagnosis. SOGC Clinical Practice Guidelines. 1998 Aug;75 [Google Scholar]

12. Dick PT. Periodic health examination, 1996 update: 1. Prenatal screening for and diagnosis of Down syndrome. Canadian Task Force on the Periodic Health Examination. Can Med J. 1996;154(4):465–79. [PMC free article] [PubMed] [Google Scholar]

13. Lince DM, Pretorius DH, Manco-Johnson D, Clewell WH. The clinical significance of increased echogenicity in the fetal abdomen. Am J Roentgenol. 1985;145:683–6. [PubMed] [Google Scholar]

14. Dicke JM, Crane JP. Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management. Obstet Gynecol. 1992;80:778–82. [PubMed] [Google Scholar]

15. Hogge WA, Hogge JS, Boehm CD, Sanders RC. Increased echogenicity in the fetal abdomen: use of DNA analysis to establish a diagnosis of cystic fibrosis. Y Ultrasound Med. 1993;12:451–4. [PubMed] [Google Scholar]

16. Bromley B, Doubilet P, Frigoletto FD, Jr, Krauss C, Est-roffJA Est-roffJA, Benacerraf BR. Is fetal hyperechoic bowel on second-trimester sonogram an indication for amniocentesis? Obstet Gynecol. 1994;83:647–51. [PubMed] [Google Scholar]

17. Nyberg DA, Dubinsky T, Resta RG, Mahony BS, Hickok DE, Luthy DA. Echogenic fetal bowel during the second trimester: clinical importance. Radiology. 1993;188:527–31. [PubMed] [Google Scholar]

18. Hill LM, Fries J, Hecker J, Grzybek P. Second-trimester echogenic small bowel: an increased risk for adverse perinatal outcome. Prenat Diagn. 1994;14:845–50. [PubMed] [Google Scholar]

19. Caspi B, Blickstein I, Appelman Z. The accuracy of the assessment of normal fetal intestinal echogenicity ¬electro-optical densitometry versus the ultrasonographer’s eye. . Gynecol Obstet Invest. 1992;33:26–30. [PubMed] [Google Scholar]

20. Blumenthal DH, Rushovich AM, Williams RK, Rochester D. Prenatal sonographic findings of meconium peritonitis with pathologic correlation. J Clin Ultrasound. 1982;10:350–2. [PubMed] [Google Scholar]

21. Foster MA, Nyberg DA, Mahony BS, Mack LA, Marks WM, Raabe RD. Meconium peritonitis: prenatal sonographic findings and their clinical significance. Radiology. 1987;165:661–5. [PubMed] [Google Scholar]

22. Sipes SL, Weiner CP, Wenstrom KD, Williamson RA, Grant SS, Mueller GM. Fetal echogenic bowel on ultrasound: is there clinical significance? Fetal Diagn Ther. 1994;9:38–43. [PubMed] [Google Scholar]

23. Fakhry J, Reiser M, Shapiro LR, Schechter A, Pait LP, Glennon A. Increased echogenicity in the lower fetal abdomen: a common normal variant in the second trimester. J Ultrasound Med. 1986;5:489–92. [PubMed] [Google Scholar]

24. Parulekar SG. Sonography of normal fetal bowel. J Ultrasound Med. 1991;10:211–20. [PubMed] [Google Scholar]

25. Fung ASL, Wilson S, Toi A, Johnson J. Echogenic colonic meconium in the third trimester: a normal sonographic finding. J Ultrasound Med. 1992;11:676–8. [PubMed] [Google Scholar]

26. Slotnick RN, Abuhamad AZ. Prognostic implications of fetal echogenic bowel. Lancet. 1996;347:85–7. [PubMed] [Google Scholar]

27. Brock DJH. A comparative study of microvillar enzyme activities in the prenatal diagnosis of cystic fibrosis. Prenat Diagn. 1985;5:129–34. [PubMed] [Google Scholar]

28. Scioscia AL, Pretorius DH, Budorick NE, Cahill TC, Axelrod FT, Leopold GR. Second-trimester echogenic bowel and chromosomal abnormalities. AmJ Obstet Gynecol. 1992;167:889–94. [PubMed] [Google Scholar]

29. Nyberg DA, Resta RG, Luthy DA, Hickok DE, Mahony BS, Hirsch JH. Prenatal sonographic findings of Down syndrome: review of 94 cases. Obstet Gynecol. 1990;76:370–7. [PubMed] [Google Scholar]

30. Vintzileos AM, Egan JFX. Adjusting the risk for trisomy 21 on the basis of second-trimester ultrasonography. AmJ Obstet Gynecol. 1995;172:837–44. [PubMed] [Google Scholar]

31. Nyberg DA, Dubinsky T, Resta RG, et al. Echogenic fetal bowel during the second trimester: clinical importance. Radiology. 1993;188:527–531. [PubMed] [Google Scholar]

32. Bromley B, Doubilet P, Frigoletto FD, et al. Is fetal hyperechogenic bowel on fetal sonogram an indication for amniocentesis. Obstet Gynecol. 1994;83:647–651. [PubMed] [Google Scholar]

33. Hill LM, Fries J, Hecker J, et al. Second trimester echo-genic small bowel: an increased risk for adverse perinatal outcome. Prenata Diagn. 1994;14:845–850. [PubMed] [Google Scholar]

34. Muller F, Dommergues M, Aubry MC, et al. Hyperechogenic fetal bowel: an Ultrasonographic marker for adverse fetal and neonatal outcome. Am J Obstet Gynecol. 1995;173:508–513. [PubMed] [Google Scholar]

35. Slotnick RN, Abuhamed AZ. Prognostic implications of fetal echogenic bowel. Lancet. 1996;347:85–87. [PubMed] [Google Scholar]

36. Yaron Y, Hassan S, Geva E, et al. Evaluation of fetal echogenic bowel in the second trimester. Fetal Diagn Ther. 1999;14:176–180. [PubMed] [Google Scholar]

37. Ghose I, Mason GC, Martinez D, et al. Hyperechogenic fetal bowel: a prospective analysis of sixty consecutive cases. Br J Obstet Gynaecol. 2000;107:426–429. [PubMed] [Google Scholar]

38. Eddleman KA, Stone JL, Berkowitz RL. Fetal echo-genic bowel: the bottom line. Contemporary Ob/Gyn. 1998;43:53–69. [Google Scholar]

39. Simon-Bouy B, Muller F. French Collaborative Group. Hyperechogenic fetal bowel and Down syndrome: results of a French collaborative study based on 680 prospective cases. Prenat Diagn. 2002;22:189–92. [PubMed] [Google Scholar]

40. Sepulveda W, Sebire NJ. Fetal echogenic bowel: a complex scenario. Ultrasound Obstet Gynecol. 2000;16:510–4. [PubMed] [Google Scholar]

41. Muller F, Aubry MC, Gasser B, Duchatel F, Boue J, Boue A. Prenatal diagnosis of cystic fibrosis. II. Meconium ileus in affected fetuses. Prenat Diagn. 1985;5:109–17. [PubMed] [Google Scholar]

42. Achiron R, Seidman DS, Horowitz A, Mashiach S, Goldman B, Lipitz S. Hyperechogenic fetal bowel and elevated serum alpha-fetoprotein: a poor fetal prognosis. Obstet Gynecol. 1996;88:368–71. [PubMed] [Google Scholar]

43. Strocker AM, Snijders RJ, Carlson DE, Greene N, Gregory KD, Walla CA, et al. Fetal echogenic bowel: parameters to be considered in differential diagnosis. Ultrasound Obstet Gynecol. 2000;16:519–23. [PubMed] [Google Scholar]

44. Strocker AM, Snijders RJ, Carlson DE, et al. Fetal echo-genic bowel: parameters to be considered in differential diagnosis. Ultrasound Obstet Gynecol. 2000;16:519–523. [PubMed] [Google Scholar]

45. Benacerraf BR. The second trimester fetus with Down syndrome detection using sonographic features. Ultrasound Obstet Gynecol. 1996;7:147–150. [PubMed] [Google Scholar]

46. Sepulveda W, Reid R, Nicolaidis P, Prendiville O, Chapman RS, Fisk NM. Second-trimester echogenic bowel and intraamniotic bleeding: association between fetal bowel echogenicity and amniotic fluid spect¬rophotometry at 410 nm. Am J Obstet Gynecol. 1996;174:839–42. [PubMed] [Google Scholar]

47. Simon-Bouy B, Satre V, Ferec C, Malinge MC, Giro-don E, Denamur E, et al. Hyperechogenic fetal bowel: a large French collaborative study of 682 cases. Am J Med Genet. 2003;121A:209–13. [PubMed] [Google Scholar]

48. Petrikovsky B, Smith-Levitin M, Holsten N. Intra-amniotic bleeding and fetal echogenic bowel. Obstet Gynecol. 1999;93:684–6. [PubMed] [Google Scholar]

49. Hill LM. Ultrasound of fetal gastrointestinal tract. In: Cal-lenPW, editors. Ultrasonography in obstetrics and gynecology Philadelphia: WB Saunders; 2000. 457 87

50. Boue A, Muller F, Nezelof C, Oury JF, Duchatel F, Dumez Y, et al. Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis. Hum Genet. 1986;74:288–97. [PubMed] [Google Scholar]

51. Berlin BM, Norton ME, Sugarman EA, Tsipis JE, Allitto BA. Cystic fibrosis and chromosome abnormalities associated with echogenic fetal bowel. Obstet Gynecol. 1999;94:135–8. [PubMed] [Google Scholar]

52. Muller F, Dommergues M, Simon-Buoy B, Ferec C, Oury JF, Autry MC, et al. Cystic fibrosis screening: a fetus with hyperechogenic bowel may be the index case. J Med Genet. 1998;35:657–60. [PMC free article] [PubMed] [Google Scholar]

53. Dicke JM, Crane JP. Sonographically detected hyperechoic fetal bowel: significance and implications for pregnancy management. Obstet Gynecol. 1992;80:778–82. [PubMed] [Google Scholar]

54. Chasen ST. Fetal echogenic bowel. In: UpToDate, version 11.2. Wellesley, MA; 2003. [28]. Achiron R, Seidman DS, Horowitz A, Mashiach S, Goldman B, Lipitz S. Hyperechogenic fetal bowel and elevated serum alpha-fetoprotein: a poor fetal prognosis.Obstet Gynecol. 1996;88:368–71. [PubMed] [Google Scholar]

55. Lam YH, Tang MHY, Lee CP, et al. Echogenic bowel in fetuses with homozygous alpha thalassemia -1 in the first and second trimesters. Ultrasound Obstet Gynecol. 1999;14:180–182. [PubMed] [Google Scholar]

56. Al-Kouatly HB, Chasen ST, Streltzoff J, Chervenak FA. The clinical significance of fetal echogenic bowel. Am J Obstet Gynecol. 2001;185:1035–8. [PubMed] [Google Scholar]

57. Blott M, Greenough A, Gamsu HR, Nicolaides K, Campbell S. Antenatal factors associated with obstruction of the gastrointestinal tract by meconium. BMJ. 1988;296:250. [PMC free article] [PubMed] [Google Scholar]

58. Ewer AK, McHugo JM, Chapman S, Newell SJ. Fetal echogenic gut: a marker of intrauterine gut ischaemia? Arch Dis Child. 1993;69:510–13. [PMC free article] [PubMed] [Google Scholar]

59. Skoll AM, Marquette GP, Hamilton EF. Prenatal ultrasonic diagnosis of multiple bowel atresias. AmJ Obstet Gynecol. 1987;156:472–3. [PubMed] [Google Scholar]

60. Porter KB, Plattner MS. Fetal abdominal hyperechoic mass: diagnosis and management. Fetal Diagn Ther. 1992;7:116–22. [PubMed] [Google Scholar]

61. Dechelotte PJ, Mulliez NM, Bouvier RJ, Vanlieferinghen PC, Lemery DJ. Pseudo-meconium ileus due to cy-tomegalovirus infection: a report of three cases. Pediatr Pathol. 1992;12:73–82. [PubMed] [Google Scholar]

62. Forouzan I. Fetal abdominal echogenic mass: an early sign of intrauterine cytomegalovirus infection. Obstet Gynecol. 1992;80:535–7. [PubMed] [Google Scholar]

64. Brock DJH. A comparative study of microvillar enzyme activities in the prenatal diagnosis of cystic fibrosis. Prenat Diagn. 1985;5:129–34. [PubMed] [Google Scholar]

65. Muller F, Aubry MC, Gasser B, Duchatel F, Boue J, Boue A. Prenatal diagnosis of cystic fibrosis. II. Meconium ileus in affected fetuses. Prenat Diagn. 1985;5:109–17. [PubMed] [Google Scholar]

66. Boue A, Muller F, Nezelof C, et al. Prenatal diagnosis in 200 pregnancies with a 1-in-4 risk of cystic fibrosis. Hum Genet. 1986;74:288. [PubMed] [Google Scholar]

67. Berry AC, Hodgson S. False positive in prenatal diagnosis of cystic fibrosis. Lancet. 1988 Jun 11; [PubMed] [Google Scholar]

68. Estroff JA, Parad RB, Benacerraf BR. Prevalence of cystic fibrosis in fetuses with dilated bowel. Radiology. 1992;183:677–80. [PubMed] [Google Scholar]

69. Muller F, Dommerguer M, Aubry MC, et al. Hypere-chogenic fetal bowel: an ultrasonographic marker for adverse fetal and neonatal outcome. AmJ Obstet Gynecol. 1995;173:508–13. [PubMed] [Google Scholar]